.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Chubb
Cerilliant
US Army
Teva
Covington
McKesson
Mallinckrodt
AstraZeneca
Cantor Fitzgerald

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018663

« Back to Dashboard

NDA 018663 describes CHYMODIACTIN, which is a drug marketed by Chart Medcl and is included in one NDA. Additional details are available on the CHYMODIACTIN profile page.

The generic ingredient in CHYMODIACTIN is chymopapain. Additional details are available on the chymopapain profile page.

Summary for 018663

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10,000 UNITS/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Nov 10, 1982TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength4,000 UNITS/VIAL
Approval Date:Aug 21, 1984TE:RLD:No

Expired Orange Book Patents for NDA: 018663

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chart MedclCHYMODIACTINchymopapainINJECTABLE;INJECTION018663-001Nov 10, 1982► Subscribe► Subscribe
Chart MedclCHYMODIACTINchymopapainINJECTABLE;INJECTION018663-002Aug 21, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Fuji
Teva
Dow
Colorcon
AstraZeneca
Merck
Boehringer Ingelheim
Fish and Richardson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot